Lee Hishammuddin Allen & Gledhill is pleased to have recently advised Ekuiti Nasional Berhad (Ekuinas), a state-owned private equity fund, on the successful acquisition of a majority stake in a leading homegrown active pharmaceutical ingredients (API) manufacturer in Southeast Asia, Symbiotica Speciality Ingredients Sdn Bhd. APIs have been identified in the New Industrial Masterplan (NIMP) 2030 as a key growth segment for the pharmaceutical sector.

“On behalf of LHAG, we would like to congratulate Ekuinas and the founders of Symbiotica on the completion of this transaction. We look forward to seeing the company move towards its next chapter of growth in the coming years.”

The LHAG deal team was led by Corporate M&A Partners Steven SY Tee and Joyce Ong Kar Yee, and supported by Associate Kerryn Toh.

For more information, the media release of this transaction can be assessed at the following links:
– DealStreetAsia
– The Edge Malaysia
– The Star Malaysia

For any queries, please contact Partners Steven SY Tee (syt@lh-ag.com) and Joyce Ong Kar Yee (oky@lh-ag.com).

8 May 2024